Indegene (BOM:544172) Change In Inventory : ₹0 Mil (TTM As of Mar. 2025)

View and export this data going back to 2024. Start your Free Trial

What is Indegene Change In Inventory?

Indegene's change in inventory for the quarter that ended in Mar. 2025 was ₹0 Mil. It means Indegene's inventory stayed the same from Dec. 2024 to Mar. 2025 .

Indegene's change in inventory for the fiscal year that ended in Mar. 2025 was ₹0 Mil. It means Indegene's inventory stayed the same from Mar. 2024 to Mar. 2025 .

Indegene's Total Inventories for the quarter that ended in Mar. 2025 was ₹0 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Inventory Turnover measures how fast the company turns over its inventory within a year.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Indegene's Inventory-to-Revenue for the quarter that ended in Mar. 2025 was 0.00.

Indegene Change In Inventory Historical Data

The historical data trend for Indegene's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Indegene Change In Inventory Chart

Indegene Annual Data

Trend

Mar21

Mar22

Mar23

Mar24

Mar25

Change In Inventory

Indegene Quarterly Data
	Mar21	Mar22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Change In Inventory	Get a 7-Day Free Trial						-	-	-	-	-

Indegene Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

Indegene (BOM:544172) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Indegene's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	0	/	0	*	365 / 4
	=	N/A

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Indegene's Inventory Turnover for the quarter that ended in Mar. 2025 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	0	/	0
	=	N/A

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Indegene's Inventory to Revenue for the quarter that ended in Mar. 2025 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	0	/	7556
	=	0.00

Indegene Change In Inventory Related Terms

Thank you for viewing the detailed overview of Indegene's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Indegene Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Indegene Ltd (BOM:544172) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

INDGN:India

Address

Outer Ring Road, Aspen Block G4, 3rd Floor, Manyata Embassy Business Park, Nagawara, Bengaluru, KA, IND, 560045

Website

https://www.indegene.com

Indegene Ltd provides digital-led commercialization services for the life sciences industry, including biopharmaceutical, emerging biotech, and medical devices companies, that assist them with drug development and clinical trials, regulatory submissions, pharmacovigilance and complaints management, and the sales and marketing of their products. Its portfolio of solutions covers all aspects of commercial, medical, regulatory, and R&D operations of life sciences companies. The company segment includes Enterprise Medical Solutions, Enterprise Commercial Solutions, Omnichannel Activation, and Others. Key revenue is generated from the Omnichannel Activation segment.

Indegene Headlines

No Headlines